Skip to content
10-K

Annual Report

VERTEX PHARMACEUTICALS INC / MA VRTX

0000875320-26-000056

← back to feed
Filed
Feb 13, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 6, 2026 254.03M sh
Shares Diluted FY 2025 · Dec 31, 2025 258M sh
Shares Diluted FY 2025 · Dec 31, 2024 257.9M sh
Shares Diluted FY 2025 · Dec 31, 2023 260.5M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $2.02B
Stock Repurchased FY 2025 · Dec 31, 2024 $1.18B
Stock Repurchased FY 2025 · Dec 31, 2023 $427.6M
Capex FY 2025 · Dec 31, 2025 $437.6M
Capex FY 2025 · Dec 31, 2024 $297.7M
Capex FY 2025 · Dec 31, 2023 $200.4M
Operating Cash Flow FY 2025 · Dec 31, 2025 $3.63B
Operating Cash Flow FY 2025 · Dec 31, 2024 −$492.6M
Operating Cash Flow FY 2025 · Dec 31, 2023 $3.54B
Cash And Equivalents FY 2025 · Dec 31, 2025 $5.08B
Cash And Equivalents FY 2025 · Dec 31, 2024 $4.57B
Cash And Equivalents FY 2025 · Dec 31, 2023 $10.37B
Cash And Equivalents FY 2025 · Dec 31, 2022 $10.5B
Stockholders Equity FY 2025 · Dec 31, 2025 $18.67B
Stockholders Equity FY 2025 · Dec 31, 2024 $16.41B
Stockholders Equity FY 2025 · Dec 31, 2023 $17.58B
Stockholders Equity FY 2025 · Dec 31, 2022 $13.91B
Current Liabilities FY 2025 · Dec 31, 2025 $3.86B
Current Liabilities FY 2025 · Dec 31, 2024 $3.56B
Total Liabilities FY 2025 · Dec 31, 2025 $6.98B
Total Liabilities FY 2025 · Dec 31, 2024 $6.12B
Current Assets FY 2025 · Dec 31, 2025 $11.2B
Current Assets FY 2025 · Dec 31, 2024 $9.6B
Total Assets FY 2025 · Dec 31, 2025 $25.64B
Total Assets FY 2025 · Dec 31, 2024 $22.53B
Eps Diluted FY 2025 · Dec 31, 2025 $15.32
Eps Diluted FY 2025 · Dec 31, 2024 −$2.08
Eps Diluted FY 2025 · Dec 31, 2023 $13.89
Eps Basic FY 2025 · Dec 31, 2025 $15.46
Eps Basic FY 2025 · Dec 31, 2024 −$2.08
Eps Basic FY 2025 · Dec 31, 2023 $14.05
Sga Expense FY 2025 · Dec 31, 2025 $1.75B
Sga Expense FY 2025 · Dec 31, 2024 $1.46B
Sga Expense FY 2025 · Dec 31, 2023 $1.14B
Net Income FY 2025 · Dec 31, 2025 $3.95B
Net Income FY 2025 · Dec 31, 2024 −$535.6M
Net Income FY 2025 · Dec 31, 2023 $3.62B
Operating Income FY 2025 · Dec 31, 2025 $4.17B
Operating Income FY 2025 · Dec 31, 2024 −$232.9M
Operating Income FY 2025 · Dec 31, 2023 $3.83B
Cost Of Revenue FY 2025 · Dec 31, 2025 $1.65B
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.53B
Cost Of Revenue FY 2025 · Dec 31, 2023 $1.26B
Revenue FY 2025 · Dec 31, 2025 $12B
Revenue FY 2025 · Dec 31, 2024 $11.02B
Revenue FY 2025 · Dec 31, 2023 $9.87B